Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease

The stratification of patients with acute lymphoblastic leukemia (ALL) into treatment risk groups based on quantification of minimal residual disease (MRD) after induction therapy is now well accepted but the relapse rate of about 20% in intermediate risk patients remains a challenge. The purpose of...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Karsa, Mawar, Dalla Pozza, Luciano, Venn, Nicola C., Law, Tamara, Shi, Rachael, Giles, Jodie E., Bahar, Anita Y., Cross, Shamira, Catchpoole, Daniel, Haber, Michelle, Marshall, Glenn M., Norris, Murray D., Sutton, Rosemary
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2013
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3795712/
https://ncbi.nlm.nih.gov/pubmed/24146872
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0076455
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires